The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease

Baker, 1984, T-cell subpopulations in the blood and skin of patients with psoriasis, Br J Dermatol, 110, 37, 10.1111/j.1365-2133.1984.tb07309.x

Valdimarsson, 1986, Psoriasis: a disease of abnormal proliferation induced by T lymphocytes, Immunol Today, 7, 256, 10.1016/0167-5699(86)90005-8

Valdimarsson, 1995, Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?, Immunol Today, 16, 145, 10.1016/0167-5699(95)80132-4

Berg, 1991, The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell–leukocyte adhesion molecule 1, J Exp Med, 174, 1461, 10.1084/jem.174.6.1461

Knibbs, 1996, The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells, J Cell Biol, 133, 911, 10.1083/jcb.133.4.911

Fuhlbrigge, 1997, Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells, Nature, 389, 978, 10.1038/40166

Bos, 1993, Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA-452 in normal human skin, Arch Dermatol Res, 285, 179, 10.1007/BF00372006

Picker, 1990, Differential expression of homing-associated adhesion molecules by T cell subsets in man, J Immunol, 145, 3247, 10.4049/jimmunol.145.10.3247

Pitzalis, 1991, Selective migration of the human helper–inducer memory T cell subset: confirmation by in vivo cellular kinetic studies, Eur J Immunol, 21, 369, 10.1002/eji.1830210218

Picker, 1991, ELAM-1 is an adhesion molecule for skin-homing T cells, Nature, 349, 796, 10.1038/349796a0

Picker, 1993, Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells, J Immunol, 150, 1122, 10.4049/jimmunol.150.3.1122

Pitzalis, 1996, Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis, Arthritis Rheum, 39, 137, 10.1002/art.1780390118

Nickoloff, 1999, Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis, Am J Pathol, 155, 145, 10.1016/S0002-9440(10)65109-7

Gilhar, 1997, T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice, J Invest Dermatol, 109, 283, 10.1111/1523-1747.ep12335758

Boehncke, 1996, Pulling the trigger on psoriasis [letter], Nature, 379, 777, 10.1038/379777a0

Boehncke, 1992, Differential expression of adhesion molecules on infiltrating cells in inflammatory dermatoses, J Am Acad Dermatol, 26, 907, 10.1016/0190-9622(92)70131-X

Onuma, 1994, Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis, J Dermatol, 21, 223, 10.1111/j.1346-8138.1994.tb01727.x

De Pita, 1996, Psoriasis: comparison of immunological markers in patients with acute and remission phase, J Dermatol Sci, 13, 118, 10.1016/s0923-1811(96)00517-8

Ferenczi, 2000, CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry, J Autoimmun, 14, 63, 10.1006/jaut.1999.0343

De Rie, 1996, Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1, Acta Derm Venereol, 76, 357, 10.2340/0001555576357360

Bonifati, 1995, Soluble E-selectin and soluble tumour necrosis factor receptor (60 kD) serum levels in patients with psoriasis, Dermatology, 190, 128, 10.1159/000246661

Krasowska, 1999, Serum level of sELAM-1 in psoriatic patients correlates with disease activity, J Eur Acad Dermatol Venereol, 12, 140, 10.1016/s0926-9959(99)00011-2

Szepietowski, 1999, Soluble E-selectin serum levels correlate with disease activity in psoriatic patients, Clin Exp Dermatol, 24, 33, 10.1046/j.1365-2230.1999.00401.x

Mussi, 1997, Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis, J Biol Regul Homeost Agents, 11, 115

Sanchez-Regana, 2000, Serum neopterin as an objective marker of psoriatic disease activity, Acta Derm Venereol, 80, 185, 10.1080/000155500750042934

Fredriksson, 1978, Severe psoriasis – oral therapy with a new retinoid, Dermatologica, 157, 238, 10.1159/000250839

Davison, 1999, Increased T-cell receptor Vbeta2 chain expression in skin homing lymphocytes in psoriasis, Br J Dermatol, 140, 845, 10.1046/j.1365-2133.1999.02813.x

Teraki, 2000, Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA) + type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis, Br J Dermatol, 143, 373, 10.1046/j.1365-2133.2000.03665.x

Tiilikainen, 1980, Psoriasis and HLA-Cw6, Br J Dermatol, 102, 179, 10.1111/j.1365-2133.1980.tb05690.x

Ikaheimo, 1996, HLA risk haplotype Cw6,DR7,DQA1*0201 and HLA–Cw6 with reference to the clinical picture of psoriasis vulgaris, Arch Dermatol Res, 288, 363, 10.1007/s004030050064

Nickoloff, 1999, Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161, Arch Dermatol, 135, 546, 10.1001/archderm.135.5.546

Nickoloff, 2000, Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system, J Dermatol Sci, 24, 212, 10.1016/s0923-1811(00)00120-1

Nickoloff, 1999, Skin innate immune system in psoriasis: friend or foe? [comment], J Clin Invest, 104, 1161, 10.1172/JCI8633

Myskowski, 1996, Dermatologic complications of HIV infection, Med Clin North Am, 80, 1415, 10.1016/S0025-7125(05)70496-X